Drugs of Abuse Testing is recommended to avoid the negative effects of drug abuse and to reduce accidents. According to the latest report from Garner Insights, the Global Drugs of Abuse Testing Services market that was valued at 1.6 billion USD in 2017 is expected to reach 2.39 billion USD by the end of 2023, growing at a CAGR of 6.9% during the forecast period 2017 to 2023.
Leading players or companies in this report include Alere and Drug Testing Laboratories such as Quest Diagnostics and Randox Laboratories.
Key factors that are contributing to this market growth include
- Rise in the number of substance abusers
- Increase in the number of government initiatives to avoid ill effects of substance abuse at workplace
- Reduced number of accidents due to consumption of illicit substance
The report divides this global market on the basis of players, countries, product types and end industries.
This market segment by type covers Alcohol, Cannabis, Cocaine, Opioids, Amphetamine and LSD. Based on applications, the market includes hospital and laboratory.
Geographically, the market is divided into North America- (United States, Canada and Mexico), Europe- (Germany, France, UK, Russia and Italy), Asia Pacific- (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, and Colombia) and the Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). While the Asia-Pacific will occupy more market share in the following years, especially China, and fast growing India and Southeast Asia regions, North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of this market. Europe also plays an important role in this global market, growing at a better CAGR% through 2023.
Drugs of abuse testing reagents and analyzers offered by reliable suppliers allow rapid drug testing. Please view our Fisher Chemical LC-MS solvents for Drugs of Abuse testing. For further questions, please contact us at 631-589-1118.